MR编号 | FR/H/0140/001 |
---|
药品名称 | Normosang |
---|
活性成分 | - [No Active-Substance specified] 0.0 -
- Human hemin 25.0 mg/ml
|
---|
剂型 | Concentrate for solution for injection |
---|
上市许可持有人 | Orphan Europe SARL |
---|
参考成员国 - 产品名称 | France (FR) Normosang |
---|
互认成员国 - 产品名称 | - Germany (DE)
Normosang 25 mg / ml Konzentrat zur Herstellung einer Infusionslösung - Denmark (DK)
- Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
- Finland (FI)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
Normosang 25 mg/ml - Konzentrat zur Herstellung einer Infusionslösung - Spain (ES)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
- Poland (PL)
Human Hemin Orphan Europe - Latvia (LV)
Normosang 25 mg/ml koncentrāts infūziju šķīduma pagatavošanai - Lithuania (LT)
Normosang 25 mg/ml koncentratas infuziniam tirpalui - Estonia (EE)
NORMOSANG - Hungary (HU)
NORMOSANG 25 mg/ml koncentrátum oldatos infúzióhoz - Cyprus (CY)
Normosang concentrate for solution for infusion 25mg/ml - Slovakia (SK)
NORMOSANG 25 mg/ml - Czechia (CZ)
- Slovenia (SI)
- Malta (MT)
|
---|
许可日期 | 1999/05/05 |
---|
最近更新日期 | 2025/01/22 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:Full Dossier Article 4.8 Di 65/65
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|